Management of Intraventricular Gradient in Patients With Aortic Stenosis.

Autor:	Angellotti D; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Losi MA; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Immobile Molaro M; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Ilardi F; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Manzo R; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Nappa D; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Canciello G; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Borrelli F; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Simonetti F; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Cirillo P; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Spaccarotella CAM; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Piccolo R; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Franzone A; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy., Esposito G; Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
Jazyk:	angličtina
Zdroj:	JACC. Case reports [JACC Case Rep] 2024 Nov 06; Vol. 29 (21), pp. 102696. Date of Electronic Publication: 2024 Nov 06 (Print Publication: 2024).
DOI:	10.1016/j.jaccas.2024.102696
Abstrakt:	In patients with severe left ventricle hypertrophy and aortic stenosis, the presence of intraventricular gradient should always be investigated. Its prompt recognition enables a precise diagnosis and safe treatment of both conditions. We report 2 cases demonstrating a successful and novel approach to this clinical situation. Competing Interests: Drs Angellotti and Simonetti are supported by a research grant provided by the CardioPath PhD program. Dr Esposito has received personal fees from Abbott Vascular, Amgen, Boehringer Ingelheim, Edwards Lifesciences, Terumo, and Sanofi, outside the submitted work; and research grants to the institution from Alvimedica, Boston Scientific, and Medtronic. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (© 2024 The Authors.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu